Arrowhead Pharmaceuticals (ARWR) Equity Income (2010 - 2026)
Arrowhead Pharmaceuticals' Equity Income was -$2.47 million in fiscal Q3 2026 (quarter ended Jun 30, 2026).
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Equity Income (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Arrowhead Pharmaceuticals' Equity Income was -$9.19 million through Jun 30, 2026; for FY2014 (ended Sep 30, 2014), it came in at -$78,874.
- In earlier fiscal years, Equity Income was -$641,141 in FY2013, -$240,154 in FY2012, -$163,180 in FY2011 and -$219,540 in FY2010.
- The fiscal Q3 2026 figure marks the highest quarterly Equity Income since fiscal Q4 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,149.64 Bn | 1,118.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 626.55 Bn | 545.08 Bn | 17.26 Bn | - |
| 3 | AbbVie | 498.79 Bn | 471.91 Bn | 12.70 Bn | - |
| 4 | Merck | 371.66 Bn | 326.04 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 299.96 Bn | 263.95 Bn | 11.24 Bn | -2.00 Mn |
| 6 | Astrazeneca | 263.22 Bn | 236.91 Bn | 12.86 Bn | -10.00 Mn |
| 7 | Amgen | 237.03 Bn | 192.43 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.20 Bn | 165.40 Bn | 6.22 Bn | - |
| 9 | Pfizer | 170.83 Bn | 117.47 Bn | 10.94 Bn | - |
| 10 | Arrowhead Pharmaceuticals | 8.31 Bn | 3.09 Bn | - | -2.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.47 Mn |
| Mar 31, 2026 | -6.72 Mn |
| Sep 30, 2014 | -9,524.00 |
| Jun 30, 2014 | 78,702.00 |
| Mar 31, 2014 | -9,597.00 |
| Dec 31, 2013 | -138,456.00 |
| Sep 30, 2013 | -260,442.00 |
| Jun 30, 2013 | -159,530.00 |
| Mar 31, 2013 | -157,612.00 |
| Dec 31, 2012 | -63,557.00 |
| Sep 30, 2012 | -34,793.00 |
| Jun 30, 2012 | -34,573.00 |
| Mar 31, 2012 | -64,261.00 |
| Dec 31, 2011 | -106,527.00 |
| Sep 30, 2011 | -66,813.00 |
| Jun 30, 2011 | -70,366.00 |
| Mar 31, 2011 | -74,827.00 |
| Dec 31, 2010 | 48,826.00 |
| Sep 30, 2010 | -53,813.00 |
| Jun 30, 2010 | -66,489.00 |
API Access
Arrowhead Pharmaceuticals Equity Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=equity-income&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "equity-income", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=equity-income&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();